These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26677991)

  • 1. Evaluation of physiotherapy in a prospective cohort of early axial spondyloarthritis. Data from the DESIR cohort.
    Escalas C; Dalichampt M; Dougados M; Poiraudeau S
    Joint Bone Spine; 2016 Mar; 83(2):185-90. PubMed ID: 26677991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerobic exercise for axial spondyloarthritis - its effects on disease activity and function as compared to standard physiotherapy: A systematic review and meta-analysis.
    Verhoeven F; Guillot X; Prati C; Mougin F; Tordi N; Demougeot C; Wendling D
    Int J Rheum Dis; 2019 Feb; 22(2):234-241. PubMed ID: 30187695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Web-based physiotherapy for people with axial spondyloarthritis (WEBPASS) - a study protocol.
    Paul L; Coulter EH; Cameron S; McDonald MT; Brandon M; Cook D; McConnachie A; Siebert S
    BMC Musculoskelet Disord; 2016 Aug; 17(1):360. PubMed ID: 27553492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of tumor necrosis factor α blockers in early axial spondyloarthritis: data from the DESIR cohort.
    Moltó A; Paternotte S; Claudepierre P; Breban M; Dougados M
    Arthritis Rheumatol; 2014 Jul; 66(7):1734-44. PubMed ID: 24623678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical presentation of patients suffering from recent onset chronic inflammatory back pain suggestive of spondyloarthritis: The DESIR cohort.
    Dougados M; Etcheto A; Molto A; Alonso S; Bouvet S; Daurès JP; Landais P; d'Agostino MA; Berenbaum F; Breban M; Claudepierre P; Combe B; Fautrel B; Feydy A; Goupille P; Richette P; Pham T; Roux C; Treluyer JM; Saraux A; van der Heijde D; Wendling D;
    Joint Bone Spine; 2015 Oct; 82(5):345-51. PubMed ID: 26190454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of nonsteroidal anti-inflammatory drugs in early axial spondyloarthritis in daily practice: Data from the DESIR cohort.
    Molto A; Granger B; Wendling D; Dougados M; Gossec L
    Joint Bone Spine; 2017 Jan; 84(1):79-82. PubMed ID: 27238187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early tumor necrosis factor α antagonist therapy in everyday practice for inflammatory back pain suggesting axial spondyloarthritis: results from a prospective multicenter french cohort.
    Canouï-Poitrine F; Poulain C; Molto A; Le Thuaut A; Lafon C; Farrenq V; Ferkal S; Le Corvoisier P; Ghaleh B; Bastuji-Garin S; Fautrel B; Dougados M; Claudepierre P
    Arthritis Care Res (Hoboken); 2014 Sep; 66(9):1395-402. PubMed ID: 24664935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brief Report: Nonsteroidal Antiinflammatory Drug-Sparing Effect of Tumor Necrosis Factor Inhibitors in Early Axial Spondyloarthritis: Results From the DESIR Cohort.
    Moltó A; Granger B; Wendling D; Breban M; Dougados M; Gossec L
    Arthritis Rheumatol; 2015 Sep; 67(9):2363-8. PubMed ID: 26109532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of anti-TNF in patients with spondyloarthritis in absence of any imaging sign.
    Bisson-Vaivre A; Alcaix D; Zarnitsky C; Pueyo L; Daragon A; Lanfant-Weybel K; Dacher JN; Vittecoq O; Le Loët X; Goëb V
    Joint Bone Spine; 2013 May; 80(3):280-6. PubMed ID: 23021158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of certolizumab pegol over ninety-six weeks in patients with axial spondyloarthritis: results from a phase III randomized trial.
    Sieper J; Landewé R; Rudwaleit M; van der Heijde D; Dougados M; Mease PJ; Braun J; Deodhar A; Kivitz A; Walsh J; Hoepken B; Nurminen T; Maksymowych WP
    Arthritis Rheumatol; 2015 Mar; 67(3):668-77. PubMed ID: 25470228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone loss in patients with early inflammatory back pain suggestive of spondyloarthritis: results from the prospective DESIR cohort.
    Briot K; Etcheto A; Miceli-Richard C; Dougados M; Roux C
    Rheumatology (Oxford); 2016 Feb; 55(2):335-42. PubMed ID: 26361878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical peripheral enthesitis in the DESIR prospective longitudinal axial spondyloarthritis cohort.
    Nadon V; Moltó A; Etcheto A; Bessette L; Michou L; D'Agostino MA; Claudepierre P; Wendling D; Haraoui P; Dougados M
    Clin Exp Rheumatol; 2019; 37(4):561-565. PubMed ID: 30620273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical activity in axial spondyloarthritis-tails from bench to bedside.
    Gensler LS
    Clin Rheumatol; 2016 Jun; 35(6):1443-5. PubMed ID: 27118200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of early supervised physiotherapy on recovery from acute ankle sprain: randomised controlled trial.
    Brison RJ; Day AG; Pelland L; Pickett W; Johnson AP; Aiken A; Pichora DR; Brouwer B
    BMJ; 2016 Nov; 355():i5650. PubMed ID: 27852621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is active sacroiliitis on MRI associated with radiographic damage in axial spondyloarthritis? Real-life data from the ASAS and DESIR cohorts.
    Sepriano A; Ramiro S; Landewé R; Dougados M; van der Heijde D; Rudwaleit M
    Rheumatology (Oxford); 2019 May; 58(5):798-802. PubMed ID: 30544144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Long-Term Etanercept Treatment on Clinical Outcomes and Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: 104-Week Results From a Randomized, Placebo-Controlled Study.
    Dougados M; van der Heijde D; Sieper J; Braun J; Citera G; Lenaerts J; van den Bosch F; Wei JC; Pedersen R; Bonin R; Jones H; Marshall L; Logeart I; Vlahos B; Bukowski JF; Maksymowych WP
    Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1590-1598. PubMed ID: 28482137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Work productivity is associated with disease activity and functional ability in Italian patients with early axial spondyloarthritis: an observational study from the SPACE cohort.
    de Hooge M; Ramonda R; Lorenzin M; Frallonardo P; Punzi L; Ortolan A; Doria A
    Arthritis Res Ther; 2016 Nov; 18(1):265. PubMed ID: 27852321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA.
    van der Heijde D; Dougados M; Landewé R; Sieper J; Maksymowych WP; Rudwaleit M; Van den Bosch F; Braun J; Mease PJ; Kivitz AJ; Walsh J; Davies O; Bauer L; Hoepken B; Peterson L; Deodhar A
    Rheumatology (Oxford); 2017 Sep; 56(9):1498-1509. PubMed ID: 28498975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled, sixteen-week study of subcutaneous golimumab in patients with active nonradiographic axial spondyloarthritis.
    Sieper J; van der Heijde D; Dougados M; Maksymowych WP; Scott BB; Boice JA; Berd Y; Bergman G; Curtis S; Tzontcheva A; Huyck S; Weng HH
    Arthritis Rheumatol; 2015 Oct; 67(10):2702-12. PubMed ID: 26139307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the validity of the different arms of the ASAS set of criteria for axial spondyloarthritis and description of the different imaging abnormalities suggestive of spondyloarthritis: data from the DESIR cohort.
    Moltó A; Paternotte S; van der Heijde D; Claudepierre P; Rudwaleit M; Dougados M
    Ann Rheum Dis; 2015 Apr; 74(4):746-51. PubMed ID: 24389295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.